查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945380

2026年全球注射给药装置市场报告

Injectable Drug Delivery Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，注射给药装置的市场规模显着成长，预计将从2025年的543亿美元成长到2026年的586.9亿美元，复合年增长率为8.1%。过去几年的成长可归因于多种因素，例如慢性病盛行率的上升、生物製药和生物相似药的推广、医院注射治疗的增加、无菌生产过程的改进以及注射装置的日益普及。

预计未来几年註射给药装置市场将稳定成长。慢性病是指持续超过三个月且病情可能随时间恶化的疾病。注射给药装置用于长期给药，预计未来几年市场规模将稳定成长。到2030年，该市场规模预计将达到795.1亿美元，复合年增长率（CAGR）为7.9%。预测期内的成长可归因于以下因素：患者越来越多地使用自我给药装置、对个人化给药的需求不断增长、生物製药製剂研发管线不断扩展、对智慧注射技术的投资增加以及居家医疗解决方案的日益普及。预测期内的主要趋势包括：预填充式注射器和安全注射器的日益普及、自动注射器和注射笔需求的增长、家庭注射疗法的日益广泛应用、可穿戴和植入式输液泵的广泛应用，以及对剂量准确性和患者安全的日益重视。

慢性病盛行率的上升预计将推动注射给药装置市场的成长。慢性病是指持续超过三个月且病情可能随时间恶化的疾病。注射给药装置为长期用药提供了可靠且方便的方法。这些装置有助于患者坚持处方治疗方案，确保有效控制慢性病，并最终改善健康。例如，总部位于瑞士的国际组织－世界卫生组织（WHO）于2024年2月预测，2050年，全球新增癌症病例将超过3,500万例，比2022年估计的2,000万例增加77%。因此，慢性病盛行率的上升将推动注射给药装置市场未来的成长。

注射给药装置市场的主要企业正致力于开发先进的解决方案，包括可穿戴式和智慧注射器，以提高患者的便利性、改善用药依从性并支持复杂治疗方法的自我给药。穿戴式和智慧注射器是创新系统，旨在精准输送药物剂量，包括生物製药和大剂量製剂，同时减少不适感、最大限度地减少使用者操作错误并改善整体治疗体验。例如，2025年1月，总部位于美国的医疗科技公司贝克顿·迪金森公司（BD）发布了多款新一代设备，包括BD Accuspray鼻喷系统、BD Hylok玻璃预充式註射器、BD Effivax玻璃预填充式注射器、BD Libertas可穿戴式註射器、BD Evolve体表笔注射器、BD Phys Phys型一次性注射器、BD Libertas可穿戴式註射器、BD Evolve体表笔注射器、BD Phys Phys型一次性注射器、BD Libertas可穿戴式註射器、BD Evolve体表笔注射器、BD Phys Physioject一次性注射器。这些解决方案采用人性化设计，方便患者自行给药；可实现生物製药和疫苗的精准稳定给药；兼容多种药物製剂；采用可穿戴式设计，方便大剂量给药；并透过一次性组件确保无菌性和安全性。此次产品发布凸显了业界向以患者为中心的先进註射给药系统转型，旨在提高患者依从性、舒适度并改善治疗效果。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球注射给药装置市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧和自主智能
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网 (IoT)、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 预填充式注射器註射器和安全注射器的使用率不断提高
    • 对自动注射器和笔式註射器的需求不断增长
    • 扩大家庭注射疗法的使用范围
    • 穿戴式和植入式输液帮浦的兴起
    • 更重视剂量准确性与病人安全

第五章 终端用户产业市场分析

  • 医院和诊所
  • 居家医疗保健服务提供者
  • 製药公司
  • 生技公司
  • 研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球注射给药装置市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球注射式药物输送装置市场规模、对比及成长率分析
  • 全球注射给药装置市场表现：规模与成长，2020-2025年
  • 全球注射给药装置市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 按类型
  • 注射器、注射器、帮浦
  • 透过使用
  • 自体免疫疾病、内分泌疾病、肿瘤学、罕见疾病、疼痛管理、呼吸系统治疗及其他应用
  • 最终用户
  • 医院和诊所、居家医疗机构、製药和生物技术公司、研究实验室以及其他最终用户
  • 按类型细分：注射器
  • 普通注射器、预填充式注射器、安全针筒
  • 按类型细分：喷油器
  • 自动注射器、笔式註射器、无针注射器
  • 按类型细分：泵
  • 胰岛素帮浦、携带式输液帮浦、植入式帮浦

第十章 区域与国家分析

  • 全球注射给药装置市场：区域分析、预测及成长，2020-2025年、2025-2030年预测、2035年预测
  • 全球注射给药装置市场：依国家划分，实际结果及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 注射式药物输送装置市场：竞争格局及市场占有率（2024年）
  • 注射式药物输送装置市场：公司估值矩阵
  • 注射式药物输送装置市场：公司概况
    • Becton, Dickinson and Company
    • Baxter International
    • Gerresheimer AG
    • Catalent, Inc.
    • Antares Pharma

第37章：其他领先和创新企业

  • Owen Mumford, West Pharmaceutical Services, Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup, Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co., Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年註射给药装置市场：提供新机会的国家
  • 2030年註射给药装置市场：充满新机会的细分市场
  • 2030年註射给药装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MIDDD01_G26Q1

Injectable Drug Delivery Devices are medical devices specifically designed to deliver medications directly into the body via injections. These devices are utilized for multiple routes of drug administration, including intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular.

The primary types of injectable drug delivery devices include conventional injectables, pre-filled syringes, auto-injectors, and pen injectors. Pre-filled syringes come with a fixed needle and contain single-dose vaccines or other medications. These devices find applications in various medical areas such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. Injectable drug delivery devices are utilized by a range of end-users, including hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others.

Tariffs are impacting the injectable drug delivery devices market by increasing costs of imported medical-grade plastics, stainless steel components, micro-needles, electronic sensors, and precision manufacturing equipment. Hospitals, pharmaceutical companies, and device manufacturers in North America and Europe are most affected due to reliance on global component sourcing, while Asia-Pacific faces cost pressure on export-oriented production. These tariffs are raising device manufacturing costs and affecting pricing strategies. However, they are also encouraging localized production, regional supplier diversification, and investments in domestic medical device manufacturing infrastructure.

The injectable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market statistics, including injectable drug delivery devices industry global market size, regional shares, competitors with a injectable drug delivery devices market share, detailed injectable drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the injectable drug delivery devices industry. This injectable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable drug delivery devices market size has grown strongly in recent years. It will grow from $54.3 billion in 2025 to $58.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of biologics and biosimilars, increasing hospital-based injectable treatments, improvements in sterile manufacturing practices, wider availability of injection devices.

The injectable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $79.51 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing shift toward self-administration devices, rising demand for personalized drug delivery, expansion of biologic drug pipelines, growing investments in smart injection technologies, increasing adoption of home healthcare solutions. Major trends in the forecast period include increasing adoption of prefilled and safety syringes, rising demand for autoinjectors and pen injectors, growing use of home-based injectable therapies, expansion of wearable and implantable infusion pumps, enhanced focus on dose accuracy and patient safety.

The rising prevalence of chronic diseases is expected to propel the growth of the injectable drug delivery devices market. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Injectable drug delivery devices offer a reliable and convenient method for the administration of medications over extended periods. These devices can enhance patient adherence to prescribed treatment regimens, ensuring the effective management of chronic conditions and ultimately leading to better health outcomes. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, there would be over 35 million new cancer cases, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the injectable drug delivery devices market going forward.

Major companies in the injectable drug delivery devices market are focusing on developing advanced solutions, including wearable and smart injectors, to enhance patient convenience, improve adherence, and support self-administration of complex therapies. Wearable and smart injectors are innovative systems designed to deliver accurate doses of medications, including biologics and large-volume formulations, while reducing discomfort, minimizing user error, and improving the overall treatment experience. For example, in January 2025, Becton, Dickinson and Company, a US-based medical technology company, launched several next-generation devices, including the BD Accuspray Nasal Spray System, BD Hylok Glass Prefillable Syringe, BD Effivax Glass Prefillable Syringe, BD Libertas Wearable Injector, BD Evolve On-body Injector, BD Physioject Disposable Autoinjector, and BD Vystra Disposable Pen. These solutions feature user-friendly designs for self-administration, precise and consistent dosing for biologics and vaccines, compatibility with diverse drug formulations, and wearable formats for large-volume delivery, while ensuring sterility and safety through disposable components. The launch highlights the industry's shift toward advanced, patient-centric injectable drug delivery systems aimed at improving adherence, comfort, and therapeutic outcomes.

In May 2025, Amneal Pharmaceuticals, Inc., a US-based provider of generic, specialty, and biosimilar pharmaceutical products, entered a strategic collaboration with Apiject Systems, Corp. to advance resilient, high-volume sterile manufacturing in the U.S. using innovative blow-fill-seal (BFS) injectable solutions. The partnership aims to increase production of sterile drug products by combining Amneal's manufacturing capabilities with Apiject's advanced BFS technology, strengthening the supply chain, expanding output, and enhancing the ability to produce injectables, ophthalmic treatments, and inhalation therapies. Apiject Systems, Corp. is a US-based medical technology company specializing in advanced drug delivery systems, including BFS-based injectable platforms.

Major companies operating in the injectable drug delivery devices market are Becton Dickinson and Company, Baxter International, Gerresheimer AG, Catalent Inc., Antares Pharma, Owen Mumford, West Pharmaceutical Services Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co. Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk

North America was the largest region in the injectable drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Syringes; Injectors; Pump
  • 2) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
  • 3) By End-user: Hospitals And Clinics; Home Healthcare Settings; Pharmaceutical And Biotechnological Companies; Research Laboratories; Other End Users
  • Subsegments:
  • 1) By Syringes: Conventional Syringes; Prefilled Syringes; Safety Syringes
  • 2) By Injectors: Autoinjectors; Pen Injectors; Needle-Free Injectors
  • 3) By Pumps: Insulin Pumps; Ambulatory Infusion Pumps; Implantable Pumps
  • Companies Mentioned: Becton Dickinson and Company; Baxter International; Gerresheimer AG; Catalent Inc.; Antares Pharma; Owen Mumford; West Pharmaceutical Services Inc.; B. Braun Melsungen AG; Ypsomed AG; AptarGroup Inc.; Nemera; Teleflex Medical; Medtronic; Caplin Steriles Limited; Hovione Technology; Jiangsu Delfu Medical Device Co. Ltd.; Terumo Corporation; Roche; Sorrel Medical; Novo Nordisk
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Injectable Drug Delivery Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Injectable Drug Delivery Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Injectable Drug Delivery Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Injectable Drug Delivery Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence And Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics And Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
    • 4.1.5 Industry 4.0 And Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Prefilled And Safety Syringes
    • 4.2.2 Rising Demand For Autoinjectors And Pen Injectors
    • 4.2.3 Growing Use Of Home-Based Injectable Therapies
    • 4.2.4 Expansion Of Wearable And Implantable Infusion Pumps
    • 4.2.5 Enhanced Focus On Dose Accuracy And Patient Safety

5. Injectable Drug Delivery Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Home Healthcare Providers
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Research Laboratories

6. Injectable Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Injectable Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Injectable Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Injectable Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Injectable Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Injectable Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Injectable Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Injectable Drug Delivery Devices Market Segmentation

  • 9.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Syringes, Injectors, Pump
  • 9.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
  • 9.3. Global Injectable Drug Delivery Devices Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
  • 9.4. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Syringes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Conventional Syringes, Prefilled Syringes, Safety Syringes
  • 9.5. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Autoinjectors, Pen Injectors, Needle-Free Injectors
  • 9.6. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps

10. Injectable Drug Delivery Devices Market Regional And Country Analysis

  • 10.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Injectable Drug Delivery Devices Market

  • 11.1. Asia-Pacific Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Injectable Drug Delivery Devices Market

  • 12.1. China Injectable Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Injectable Drug Delivery Devices Market

  • 13.1. India Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Injectable Drug Delivery Devices Market

  • 14.1. Japan Injectable Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Injectable Drug Delivery Devices Market

  • 15.1. Australia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Injectable Drug Delivery Devices Market

  • 16.1. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Injectable Drug Delivery Devices Market

  • 17.1. South Korea Injectable Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Injectable Drug Delivery Devices Market

  • 18.1. Taiwan Injectable Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Injectable Drug Delivery Devices Market

  • 19.1. South East Asia Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Injectable Drug Delivery Devices Market

  • 20.1. Western Europe Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Injectable Drug Delivery Devices Market

  • 21.1. UK Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Injectable Drug Delivery Devices Market

  • 22.1. Germany Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Injectable Drug Delivery Devices Market

  • 23.1. France Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Injectable Drug Delivery Devices Market

  • 24.1. Italy Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Injectable Drug Delivery Devices Market

  • 25.1. Spain Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Injectable Drug Delivery Devices Market

  • 26.1. Eastern Europe Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Injectable Drug Delivery Devices Market

  • 27.1. Russia Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Injectable Drug Delivery Devices Market

  • 28.1. North America Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Injectable Drug Delivery Devices Market

  • 29.1. USA Injectable Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Injectable Drug Delivery Devices Market

  • 30.1. Canada Injectable Drug Delivery Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Injectable Drug Delivery Devices Market

  • 31.1. South America Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Injectable Drug Delivery Devices Market

  • 32.1. Brazil Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Injectable Drug Delivery Devices Market

  • 33.1. Middle East Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Injectable Drug Delivery Devices Market

  • 34.1. Africa Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Injectable Drug Delivery Devices Market, Segmentation By Type, Segmentation By Application, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Injectable Drug Delivery Devices Market Regulatory and Investment Landscape

36. Injectable Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 36.1. Injectable Drug Delivery Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Injectable Drug Delivery Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Injectable Drug Delivery Devices Market Company Profiles
    • 36.3.1. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Baxter International Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Catalent, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Antares Pharma Overview, Products and Services, Strategy and Financial Analysis

37. Injectable Drug Delivery Devices Market Other Major And Innovative Companies

  • Owen Mumford, West Pharmaceutical Services, Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup, Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co., Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk

38. Global Injectable Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market

40. Injectable Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Injectable Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Injectable Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Injectable Drug Delivery Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer